» Articles » PMID: 19154608

Restorative Effect of Endurance Exercise on Behavioral Deficits in the Chronic Mouse Model of Parkinson's Disease with Severe Neurodegeneration

Overview
Journal BMC Neurosci
Publisher Biomed Central
Specialty Neurology
Date 2009 Jan 22
PMID 19154608
Citations 58
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Animal models of Parkinson's disease have been widely used for investigating the mechanisms of neurodegenerative process and for discovering alternative strategies for treating the disease. Following 10 injections with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP, 25 mg/kg) and probenecid (250 mg/kg) over 5 weeks in mice, we have established and characterized a chronic mouse model of Parkinson's disease (MPD), which displays severe long-term neurological and pathological defects resembling that of the human Parkinson's disease in the advanced stage. The behavioral manifestations in this chronic mouse model of Parkinson's syndrome remain uninvestigated. The health benefit of exercise in aging and in neurodegenerative disorders including the Parkinson's disease has been implicated; however, clinical and laboratory studies in this area are limited. In this research with the chronic MPD, we first conducted a series of behavioral tests and then investigated the impact of endurance exercise on the identified Parkinsonian behavioral deficits.

Results: We report here that the severe chronic MPD mice showed significant deficits in their gait pattern consistency and in learning the cued version of the Morris water maze. Their performances on the challenging beam and walking grid were considerably attenuated suggesting the lack of balance and motor coordination. Furthermore, their spontaneous and amphetamine-stimulated locomotor activities in the open field were significantly suppressed. The behavioral deficits in the chronic MPD lasted for at least 8 weeks after MPTP/probenecid treatment. When the chronic MPD mice were exercise-trained on a motorized treadmill 1 week before, 5 weeks during, and 8-12 weeks after MPTP/probenecid treatment, the behavioral deficits in gait pattern, spontaneous ambulatory movement, and balance performance were reversed; whereas neuronal loss and impairment in cognitive skill, motor coordination, and amphetamine-stimulated locomotor activity were not altered when compared to the sedentary chronic MPD animals.

Conclusion: This study indicates that in spite of the drastic loss of dopaminergic neurons and depletion of dopamine in the severe chronic MPD, endurance exercise training effectively reverses the Parkinson's like behavioral deficits related to regular movement, balance and gait performance.

Citing Articles

Steady Moderate Exercise Confers Resilience Against Neurodegeneration and Neuroinflammation in a Mouse Model of Parkinson's Disease.

Palasz E, Gasiorowska-Bien A, Drapich P, Niewiadomski W, Niewiadomska G Int J Mol Sci. 2025; 26(3).

PMID: 39940916 PMC: 11818830. DOI: 10.3390/ijms26031146.


Aerobic exercise improves depressive symptoms in the unilateral 6-OHDA-lesioned rat model of Parkinson's disease.

Loughlin H, Jackson J, Looman C, Starll A, Goldman J, Shan Z IBRO Neurosci Rep. 2024; 16:468-475.

PMID: 38560366 PMC: 10981038. DOI: 10.1016/j.ibneur.2024.03.004.


Effect of Upper Limb Motor Rehabilitation on Cognition in Parkinson's Disease: An Observational Study.

Varalta V, Evangelista E, Righetti A, Morone G, Tamburin S, Picelli A Brain Sci. 2022; 12(12).

PMID: 36552144 PMC: 9775162. DOI: 10.3390/brainsci12121684.


Parkinsonics: A Randomized, Blinded, Cross-Over Trial of Group Singing for Motor and Nonmotor Symptoms in Idiopathic Parkinson Disease.

Butala A, Li K, Swaminathan A, Dunlop S, Salnikova Y, Ficek B Parkinsons Dis. 2022; 2022:4233203.

PMID: 36247106 PMC: 9553721. DOI: 10.1155/2022/4233203.


Neurochemical, histological, and behavioral profiling of the acute, sub-acute, and chronic MPTP mouse model of Parkinson's disease.

Santoro M, Fadda P, Klephan K, Hull C, Teismann P, Platt B J Neurochem. 2022; 164(2):121-142.

PMID: 36184945 PMC: 10098710. DOI: 10.1111/jnc.15699.


References
1.
Schaafsma J, Giladi N, Balash Y, Bartels A, Gurevich T, Hausdorff J . Gait dynamics in Parkinson's disease: relationship to Parkinsonian features, falls and response to levodopa. J Neurol Sci. 2003; 212(1-2):47-53. DOI: 10.1016/s0022-510x(03)00104-7. View

2.
Hornykiewicz O . Dopamine and extrapyramidal motor function and dysfunction. Res Publ Assoc Res Nerv Ment Dis. 1972; 50:390-415. View

3.
Baskin Y, Dietrich W, Green E . Two effective behavioral tasks for evaluating sensorimotor dysfunction following traumatic brain injury in mice. J Neurosci Methods. 2003; 129(1):87-93. DOI: 10.1016/s0165-0270(03)00212-7. View

4.
Miyai I, Fujimoto Y, Ueda Y, Yamamoto H, Nozaki S, Saito T . Treadmill training with body weight support: its effect on Parkinson's disease. Arch Phys Med Rehabil. 2000; 81(7):849-52. DOI: 10.1053/apmr.2000.4439. View

5.
Lau Y, Trobough K, Crampton J, Wilson J . Effects of probenecid on striatal dopamine depletion in acute and long-term 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated mice. Gen Pharmacol. 1990; 21(2):181-7. DOI: 10.1016/0306-3623(90)90898-v. View